Unlock stock picks and a broker-level newsfeed that powers Wall Street.
40.33
-6.67
(-14.20%)
At close: April 4 at 4:13:47 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 9 |
| Avg. Estimate | 2.16B | 1.78B | 8.27B | 9.51B |
| Low Estimate | 2.02B | 1.53B | 7.6B | 7.99B |
| High Estimate | 2.25B | 2.02B | 8.91B | 11.49B |
| Year Ago Sales | 1.41B | 952.51M | 5.27B | 8.27B |
| Sales Growth (year/est) | 52.63% | 87.24% | 56.90% | 14.99% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EQ6.F | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Maintains | Mizuho: Outperform to Outperform | 4/1/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/27/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/19/2025 |
| Upgrade | Stephens & Co.: Equal-Weight to Overweight | 3/18/2025 |
| Maintains | Citigroup: Buy to Buy | 3/17/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/13/2025 |